Physician profile
Silpa Joy
NPI 1649629866
$2,232.97
in general payments reported to CMS, 2019-2025
16 companies · $54.23 in 2025
The $54.23 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,932 · 2020: $13.80 · 2023: $91.40 · 2024: $141 · 2025: $54.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,754.00 | 2019 | |
| Medline Industries LP | $82.52 | 2019 | |
| Stryker Corporation | $63.56 | 2024 | Allowrap |
| Nevro Corp. | $62.61 | 2023-2024 | Senza |
| Orthofix Medical, INC. | $38.94 | 2024 | Physio-Stim |
| Kerecis Limited | $36.23 | 2019 | |
| Globus Medical, INC. | $36.12 | 2025 | Senza |
| Smith+Nephew, INC. | $33.40 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $21.80 | 2023 | |
| Amgen INC. | $18.11 | 2025 | Krystexxa |
| Horizon Therapeutics Plc | $16.55 | 2023 | Krystexxa |
| Ovik Health, LLC | $15.95 | 2019 | |
| Convatec INC. | $15.45 | 2023 | |
| Treace Medical Concepts, INC. | $13.68 | 2023 | |
| Novum Pharma, LLC | $12.79 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silpa Joy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.